%function [DCM,GCM] = DEM_COVID(data)
% Demonstration of COVID-19 modelling using variational Laplace
%__________________________________________________________________________
%
% This routine illustrates the Bayesian model inversion of a generative
% model of coronavirus spread using variational techniques (variational
% Laplace). It illustrates hierarchical Bayesian modelling by first
% inverting a generative model of each country, and then combining the
% posterior densities over the model parameters using parametric empirical
% Bayesto leverage systematic differences between countries, as
% characterised by their population, geographical location etc.
%
% This routine produces a series of figures illustrating parameter
% estimates and their associated confidence intervals. It then moves on to
% look at timeseries predictions for a specific country (currently
% hardcoded to be United Kingdom). It considers the effects of various
% model parameters such as those encoding the degree of social distancing
% and initial (herd) immunity.
%
% Each subsection produces one or two figures that are described in the
% annotated (Matlab)code. These subsections core various subroutines that
% provide a more detailed description of things like the generative model,
% its priors and the evaluation confidence intervals.
%__________________________________________________________________________
% Copyright (C) 2005 Wellcome Trust Centre for Neuroimaging

% Karl Friston
% $Id: DEM_demo_MDP_fit_fields.m 6939 2016-11-20 13:33:56Z karl $ 

% F: -1.5701e+04 social distancing based upon P(infected)
% F: -1.5969e+04 social distancing based upon P(symptomatic)
% F: -1.5909e+04 social distancing based upon P(waiting)
% F = 0; for i = 1:numel(DCM), F = F + DCM{1}.F; end, disp(F)

clear all
close all

 
 
 
% assemble (Gaussian) priors over model parameters
%--------------------------------------------------------------------------
[pE,pC,str] = spm_COVID_priors;

% Bayesian inversion (placing posteriors in a cell array of structures)
%--------------------------------------------------------------------------
load 'data_all_to_April_5'
countries_test = {'Ireland','United Kingdom','Italy','Spain','France','Germany','Switzerland'};
 
 
for countries = 1:7
    
    use_c        = find(countries_hubei==countries_test{countries}) ;
    %---- data
   
    % data for this country (here, and positive test rates)
    %----------------------------------------------------------------------
 
    %Y   = [data(i).death, data(i).cases]; %% days x 2
    Y = [data_all.deaths_diff(use_c,:)',  data_all.cases_diff(use_c,:)'];
    
    % variational Laplace (estimating log evidence (F) and posteriors)
    %======================================================================
    [F,Ep,Cp,pE,pC] = spm_COVID(Y,pE,pC);
    
    % assemble prior and posterior estimates (and log evidence)
    %----------------------------------------------------------------------
    DCM.M.pE = pE;
    DCM.M.pC = pC;
    DCM.Ep   = Ep;
    DCM.Cp   = Cp;
    DCM.F    = F;
    
 
    DCM.M.pC.N = 1/128;
    
   [Z,X] = spm_COVID_gen(DCM.Ep,DCM.M,4);
   spm_COVID_plot(Z,X,Y)

    % save this country (in a cell array)
    %----------------------------------------------------------------------
     GCM{countries}   = DCM;
     
 end
  save('Friston_GCM_1_7','GCM');
  
% 
% % Between country analysis (hierarchical or parametric empirical Bayes)
% %==========================================================================
% spm_figure('GetWin','Bayesian model reduction'); clf;
% %--------------------------------------------------------------------------
% % (Bayesian model comparison). This figure with reports the result of
% % Bayesian model comparison (a.k.a. Bayesian model reduction). In this
% % instance, the models compared are at the second or between country level.
% % In other words, the models compared contained all combinations of (second
% % level) parameters (a parameter is removed by setting its prior covariance
% % to zero). If the model evidence increases – in virtue of reducing model
% % complexity – then this parameter is redundant. The redundant parameters
% % are shown in the lower panels by comparing the posterior expectations
% % before and after Bayesian model reduction. The blue bars correspond to
% % posterior expectations, while the pink bars denote 90% Bayesian credible
% % intervals. The key thing to take from this analysis is that a large
% % number of second level parameters are redundant. These second level
% % parameters encode the effects of population size and geographical
% % location, on each of the parameters of the generative model. The next
% % figure illustrates the nonredundant effects that can be inferred with
% % almost a 100% posterior confidence.
% 
% % general linear model (constant, log-population, latitude and longitude)
% %--------------------------------------------------------------------------
% lat    = spm_vec([data.lat]);
% lon    = spm_vec([data.long]);
% lat    = lat*2*pi/360;
% lon    = lon*2*pi/360;
% X      = [];
% Xn     = {'const','log cell size'};
% for  i = 1:4
%     X  = [X sin(i*lon) sin(i*lat)];
%     Xn = {Xn{:}, sprintf('lat(%d)',i), sprintf('lon(%d)',i)};
% end
% 
% X      = [log(spm_vec([data.pop])) X];
% X      = [ones(numel(data),1) X];
% X      = spm_orth(X,'norm');
% X(:,1) = 1;
% GLM.X  = X;
% GLM.Xnames = Xn;
% 
% % parametric empirical Bayes (with random effects in str.field)
% %--------------------------------------------------------------------------
% [PEB,DCM] = spm_dcm_peb(GCM,GLM,str.field);
% 
% % Bayesian model averaging (over reduced models), testing for GLM effects
% %--------------------------------------------------------------------------
% [BMA,BMR] = spm_dcm_bmr_all(PEB,str.field);
% 
% % Bayesian parameter averaging (over countries)
% %--------------------------------------------------------------------------
% BPA       = spm_dcm_bpa(DCM,'nocd');
% 
% 
% % illustrate the largest between country effects
% %==========================================================================
% spm_figure('GetWin','Second level effects'); clf;
% %--------------------------------------------------------------------------
% % (between country effects). This figure shows the relationship between
% % certain parameters of the generative model and the explanatory variables
% % in a general linear model of between country effects. The examples are
% % based upon a ranking of the absolute value of the second level parameter;
% % namely, the contribution of an explanatory variable to a model parameter.
% % Here, the effective size of the population cell appears to depend upon
% % the latitude of a country.
% 
% % assemble parameters
% %--------------------------------------------------------------------------
% P     = [];                                   % posterior expectations
% C     = [];                                   % posterior variances
% for i = 1:numel(DCM)
%     P(:,i) = spm_vec(DCM{i}.Ep);
% end
% P     = P(PEB.Pind,:);
% Pname = str.names(PEB.Pind);
% 
% % find largest absolute (second level) effects and plot
% %--------------------------------------------------------------------------
% Ep      = abs(PEB.Ep);
% Ep(:,1) = 0;
% Sp      = sort(Ep(:),'descend');
% 
% for i = 1:6
%     [I,J] = find(Ep == Sp(i));
%     subplot(3,2,i), plot(X(:,J),P(I,:),'.','MarkerSize',32,'Color',[0.8 0.8 1])
%     xlabel(PEB.Xnames{J}),ylabel([ 'log ' Pname{I}])
%     title(Pname{I},'FontSize',16),axis square, box off
% end
% 
% % report Bayesian parameter averages, in relation to priors
% %--------------------------------------------------------------------------
% spm_figure('GetWin','Parameter estimates'); clf;
% %--------------------------------------------------------------------------
% % (Bayesian parameter averages). This figure reports the Bayesian parameter
% % averages over countries following a hierarchical or parametric empirical
% % Bayesian analysis that tests for – and applies shrinkage priors to –
% % posterior parameter estimates for each country. The upper panel shows the
% % parameters as estimated in log space, while the lower panel shows the
% % same results for the corresponding scale parameters (scale parameters are
% % nonnegative parameters). The blue bars report posterior expectations,
% % while the thin red bars are prior expectations. The pink bars denote 90%
% % Bayesian confidence or credible intervals. One can interpret these
% % parameters as the average value for any given parameter of the generative
% % model, to which a random (country specific) effect is added to generate
% % the ensemble dynamics for each country. In turn, these ensemble
% % distributions determine the likelihood of various outcome measures under
% % larger number (i.e., Poisson) assumptions. For example, the average
% % number of interpersonal contacts (that are potentially contagious) at
% % home is about four, while at work it is about 24. The two phases of
% % infection (infected and contagious) are roughly the same at around five
% % days. Notice that these estimates are not based upon empirical data.
% % These are the periods that provide the best explanation for the new cases
% % and deaths, reported from each country.
% 
% Ep = BPA.Ep;                                  % posterior expectations                         
% Cp = BPA.Cp;                                  % posterior covariances
% 
% subplot(2,1,1)
% spm_plot_ci(Ep,Cp), hold on, bar(spm_vec(pE),1/4), hold off
% ylabel('log parameters','FontSize',16)
% set(gca,'XTick',1:spm_length(Ep),'Xticklabel',str.names)
% camorbit(90,0), axis square, box off
% 
% subplot(2,1,2)
% spm_plot_ci(Ep,Cp,[],[],'exp')
% set(gca,'yLim',[0 32])
% set(gca,'XTick',1:spm_length(Ep),'Xticklabel',str.names)
% ylabel('Parameters','FontSize',16)
% camorbit(90,0), axis square, box off
% 
% 
% % Differences among countries, in terms of parameters
% %==========================================================================
% spm_figure('GetWin','Parameters');
% %--------------------------------------------------------------------------
% % (differences among countries). This figure reports the differences among
% % countries in terms of selected parameters of the generative model,
% % ranging from the size of a cell (i.e., the effective size of an infected
% % population), through to the probability of dying when in critical care.
% % Interesting country specific differences here include an apparent
% % attenuation of social distancing responses, relative to other countries,
% % in the United States and Australia. The blue bars represent the posterior
% % expectations, while the pink bars are 90% Bayesian credible intervals.
% % Notice that these intervals are not symmetrical about the mean because
% % scale parameters are plotted here – as opposed to the log parameters. The
% % next figure illustrates the predictions – in terms of new deaths and
% % cases – based upon these parameter estimates.
% 
% % assemble parameters
% %--------------------------------------------------------------------------
% P     = [];                                   % posterior expectations
% C     = [];                                   % posterior variances
% for i = 1:numel(DCM)
%     P(:,i) = spm_vec(DCM{i}.Ep);
%     C(:,i) = diag(DCM{i}.Cp);
% end
% 
% % report selected parameters (see spm_COVID_priors)
% %--------------------------------------------------------------------------
% Np    = spm_length(pE);
% j     = 1:Np; j([1,3,5,7,11,15,18,19,21]) = [];
% for i = 1:length(j)
%     subplot(4,3,i) 
%     spm_plot_ci(P(j(i),:)',C(j(i),:),[],[],'exp')
%     title(str.names{j(i)},'FontSize',16)
%     xlabel('country'), axis square, box off
% end
% 
% 
% % Country specific predictions
% %==========================================================================
% country = 'United Kingdom';                       % country to predict
% i       = find(ismember({data.country},country)); % country index
% Y       = [data(i).death, data(i).cases];         % empirical data
% M.T     = 180;                                    % six-month period
% Ep      = DCM{i}.Ep;                              % posterior expectations
% Cp      = DCM{i}.Cp;                              % posterior covariances
% 
% % show projections in terms of confidence intervals and superimpose data
% %--------------------------------------------------------------------------
% spm_figure('GetWin',country); clf;
% %--------------------------------------------------------------------------
% % (predicted outcomes). This figure provides an example of predicted new
% % deaths and cases (and recovery rates and its critical care unit
% % occupancy) for an exemplar country; here, the United Kingdom. The panels
% % on the left shows the predicted outcomes as a function of weeks. The blue
% % line corresponds to the expected trajectory, while the shaded areas are
% % 90% Bayesian credible intervals. The black dots represent empirical data,
% % upon which the parameter estimates are based. The lower right panel shows
% % the parameter estimates for the country in question. As in previous
% % figures, the prior expectations are shown as in bars over the posterior
% % expectations (and credible intervals). The upper right panel illustrates
% % the equivalent expectations in terms of cumulative deaths. The key point
% % to take from this figure is the quantification of uncertainty inherent in
% % the credible or confidence intervals. In other words, uncertainty about
% % the parameters propagates through to uncertainty in predicted outcomes.
% % This uncertainty changes over time because of the non-linear relationship
% % between model parameters and ensemble dynamics. By model design, one can
% % be certain about the final states; however, uncertainty about cumulative
% % death rates itself accumulates. The mapping from parameters, through
% % ensemble dynamics to outcomes is mediated by latent or hidden states. The
% % trajectory of these states is illustrated in the subsequent figure.
% 
% spm_COVID_ci(Ep,Cp,Y)
% 
% % and plot latent or hidden states
% %--------------------------------------------------------------------------
% spm_figure('GetWin',['Predictions: ' country]); clf;
% %--------------------------------------------------------------------------
% % (latent causes of observed consequences). The upper panels reproduce the
% % expected trajectories of the previous figure, for an example country
% % (here the United Kingdom) in. Here, the expected death rate is shown in
% % blue, new cases in red, predicted recovery rate in orange and CCU
% % occupancy in puce. The black dots correspond to empirical data. The lower
% % four panels show the evolution of latent (ensemble) dynamics, in terms of
% % the expected probability of being in various states. The first (location)
% % panel shows that after about 5 to 6 weeks, there is sufficient evidence
% % for the onset of an episode to induce social distancing, such that the
% % probability of being found at work falls, over a couple of weeks to
% % negligible levels. At this time, the number of infected people increases
% % (to about 18%) with a concomitant probability of being infectious a few
% % days later. During this time, the probability of becoming immune
% % increases monotonically and saturates, within this cell, at about 20
% % weeks. Clinically, the probability of becoming symptomatic rises to about
% % 20%, with a small probability of developing acute respiratory distress
% % and, possibly death. In terms of testing, there is a progressive increase
% % in the number of people tested, with a concomitant decrease in those
% % untested or waiting for their results. Interestingly, initially the
% % number of negative tests increases monotonically, while the proportion of
% % positive tests catches up during the peak of the episode. Under these
% % parameters, the entire episode lasts for about 12 weeks or three months.
% % The increase in (herd) immunity is interesting and will become important
% % later. One might ask to what extent these trajectories depend upon
% % different model parameters. This is quantified in the next figure.
% 
% [Z,X] = spm_COVID_gen(DCM{i}.Ep,M,4);
% spm_COVID_plot(Z,X,Y)
% 
% 
% % Sensitivity analysis: which factors determine cumulative deaths?
% %==========================================================================
% spm_figure('GetWin',['Sensitivity: ' country]);
% %--------------------------------------------------------------------------
% % (sensitivity analysis). These panels show the change in outcome measures
% % (upper panel: death rate. lower panel: new cases). The bar charts are the
% % derivatives of outcomes with respect to each of the parameters. Positive
% % values (on the right) exacerbate new cases when increased, while,
% % conversely, negative values (on the left) decrease new cases. As one
% % might expect, increasing social distancing, bed availability and the
% % probability of survival outside critical care, tend to decrease death
% % rate. Interestingly, increasing both the period of symptoms and ARDS
% % decreases overall death rate; presumably, because there is more time to
% % recover to an asymptomatic state and the probability of infecting someone
% % else – when symptomatic – is attenuated. The next figure focuses on the
% % effects of social distancing as a way of ameliorating the impact on
% % deaths.
% 
% % sensitivity analysis in terms of partial derivatives
% %--------------------------------------------------------------------------
% [dYdP,Y] = spm_diff(@(P,M,U)spm_COVID_gen(P,M,U),Ep,M,2,1);
% Ny       = size(Y,2);
% 
% % cumulative effects over time
% %--------------------------------------------------------------------------
% for i = 1:Ny
%     for j = 1:size(dYdP,2)
%         D{j} = dYdP{j}(:,i);
%     end
%     dRdP{i}  = sum(spm_cat(D));
% end
% 
% % plot results
% %--------------------------------------------------------------------------
% for i = 1:Ny
%     subplot(Ny,1,i)
%     bar(dRdP{i})
%     set(gca,'XTick',1:spm_length(Ep),'Xticklabel',str.names,'FontSize',8)
%     ylabel(str.outcome{i},'FontSize',16), box off
%     camorbit(90,0),axis square
% end
% 
% 
% % Illustrate the effect of social distancing
% %==========================================================================
% spm_figure('GetWin',['Social distancing:' country]); clf;
% %--------------------------------------------------------------------------
% % (the effects of social distancing). This figure uses the same format as
% % Figure 9. However, here trajectories are reproduced under different
% % levels of social distancing; from zero through to 4 (in 16 steps). This
% % parameter is the exponent applied to the probability of not being
% % infected. In other words, it scores the sensitivity of social distancing
% % to the prevalence of the virus in the population. In this example (based
% % upon posterior expectations for the United Kingdom), death rates (per
% % day) and underlying latent states of the population decrease
% % progressively with social distancing. The cumulative death rate is shown
% % as a function of social distancing in the upper right panel. The vertical
% % line corresponds to the posterior expectation of the social distancing
% % exponent for this country. These results suggest that social distancing
% % relieves pressure on critical care capacities and ameliorates cumulative
% % deaths by about 3700 people. This is roughly four times the number of
% % people who die in the equivalent period due to road traffic accidents. In
% % the next figure, we repeat this analysis but looking at the effect of
% % herd immunity.
% 
% % increase social distancing exponent from 0 to 4
% %--------------------------------------------------------------------------
% P     = Ep;                                    % expansion point
% sde   = linspace(0,4,16);                      % range of social distancing
% S     = sde;
% for i = 1:numel(sde)
%     P.sde  = Ep.sde + log(sde(i) + 1e-6);
%     [Y,X]  = spm_COVID_gen(P,M,1);
%     S(i)   = sum(Y);
%     
%     % plot results and hold graph
%     %----------------------------------------------------------------------
%     spm_COVID_plot(Y,X)
%     for j = 1:6, subplot(3,2,j), hold on, end
% end
% 
% % cumulative deaths as a function of social distancing
% %--------------------------------------------------------------------------
% subplot(3,2,2), hold off
% plot(sde,S,[1 1]*exp(Ep.sde),[min(S) max(S)],'-.')
% title('Social distancing','FontSize',16), 
% xlabel('social distancing exponent')
% ylabel('cumulative deaths')
% axis square,box off
% 
% 
% % Herd immunity
% %==========================================================================
% spm_figure('GetWin',['Herd immunity:' country]); clf;
% %--------------------------------------------------------------------------
% % (herd immunity). This figure reproduces the format of the previous
% % figure. However, here, we increased the initial proportion of the cell
% % (i.e., population) who were initially immune. Increasing the initial
% % immunity dramatically decreases death rates with a fall in the cumulative
% % deaths from several thousand to negligible levels with a herd immunity of
% % about 70%. The dashed line in the upper panel shows the equivalent deaths
% % over the same time period due to seasonal flu (based upon 2019 figures).
% % This death rate would require an initial or herd immunity of about 60%.
% % It is interesting to return to Figure 6 and identify at what point –
% % during the course of the infection episode – this level of herd immunity
% % is obtained.
% 
% %--------------------------------------------------------------------------
% % Public Health England estimates that on average 17,000 people have died
% % from the flu in England annually between 2014/15 and 2018/19. However,
% % the yearly deaths vary widely, from a high of 28,330 in 2014/15 to a low
% % of 1,692 in 2018/19. Public Health England does not publish a mortality
% % rate for the flu.
% 
% % The Department for Transport (DfT) has announced there were 1,784
% % reported road deaths in 2018, compared to 1,793 reported in 2017 – a 1%
% % fall. There were 25,511 people seriously injured in reported road traffic
% % accidents in 2018, compared to 24,831 in 2017 – a 3% year-on-year
% % increase
% %--------------------------------------------------------------------------
% 
% % progressively increase initial immunity
% %--------------------------------------------------------------------------
% FLU   = 1692/365;                  % death rate for seasonal flu (per day)
% m     = linspace(0,1,16);          % range of initial immunity
% P     = Ep;
% S     = m;
% for i = 1:numel(m)
%     P.m   = log(m(i) + 1e-6);
%     [Y,X] = spm_COVID_gen(P,M,1);
%     S(i)  = sum(Y);
%     
%     % plot results and hold graph
%     %----------------------------------------------------------------------
%     spm_COVID_plot(Y,X)
%     for j = 1:6, subplot(3,2,j), hold on, end
%     
% end
% 
% % plot
% %--------------------------------------------------------------------------
% subplot(3,2,2), hold off
% plot(m,S,m,FLU*M.T*m.^0,'-.')
% title('Herd immunity','FontSize',16), 
% xlabel('proportion immune')
% ylabel('cumulative deaths')
% axis square,box off
% 
% 
% % demonstrate routines: predictive validity
% %==========================================================================
% % (predictive validity – early). This figure uses the same format as Figure
% % 5; however, here, the posterior estimates are based upon partial data,
% % from early in the timeseries for an exemplar country. These estimates are
% % based upon the empirical priors following parametric empirical Bayes. The
% % red dots show the outcomes that were observed but not used to estimate
% % the expected trajectories (or confidence intervals). This example
% % illustrates the predictive validity of the estimates for a two-week
% % period following the last datapoint. This captures the rise to the peak
% % of new cases in Italy.
% 
% % remove ( > T) data from country ( = i)
% %--------------------------------------------------------------------------
% % T           = 35;                         % number of days to withhold
% % i           = 1;                          % country index
% T             = 14;                         % number of days to withhold
% i             = 2;                          % country index
% 
% 
% 
% % use priors from parametric empirical Bayes
% %--------------------------------------------------------------------------
% pE            = DCM{i}.M.pE;
% pC            = DCM{i}.M.pC;
% data          = DATA_COVID_JHU;
% data(i).death = data(i).death(1:end - T);
% data(i).cases = data(i).cases(1:end - T);
% 
% % invert (using incomplete data) and plot confidence intervals
% %--------------------------------------------------------------------------
% Y             = [data(i).death, data(i).cases];
% [F,Ep,Cp]     = spm_COVID(Y,pE,pC);
% 
% spm_figure('GetWin','predictive validity'); clf
% spm_COVID_ci(Ep,Cp,Y)
% 
% % retrieve and overlay withheld data
% %--------------------------------------------------------------------------
% data = DATA_COVID_JHU;
% Y    = [data(i).death, data(i).cases];
% NY   = size(Y,1);
% t    = (1:NY)/7;
% CY   = cumsum(Y(:,1));
% i    = (NY - T):NY;
% t    = t(i);
% 
% spm_figure('GetWin','predictive validity');
% subplot(4,2,1), hold on, plot(t,Y(i,1),'.r','MarkerSize',16)
% subplot(4,2,3), hold on, plot(t,Y(i,2),'.r','MarkerSize',16)
% subplot(2,2,2), hold on, plot(t,CY(i), '.r','MarkerSize',16)
% 
% return
% 
% 
% 
% % % auxiliary routines
% % %__________________________________________________________________________
% % 
% % 
% % % demonstrate routines: face validation of inversion scheme
% % %==========================================================================
% % 
% % % Gaussian priors over model parameters
% % %--------------------------------------------------------------------------
% % [pE,pC,str] = spm_COVID_priors;
% % 
% % % Sample model parameters from prior distribution
% % %--------------------------------------------------------------------------
% % dP    = diag(sqrt(spm_vec(pC)))*randn(spm_length(pE),1);
% % P     = spm_unvec(spm_vec(pE) + dP,pE);
% % [Y,X] = spm_COVID_gen(P,M,2);
% % 
% % % plot synthetic data
% % %--------------------------------------------------------------------------
% % spm_COVID_plot(Y,X)
% % 
% % % Variational Laplace
% % %==========================================================================
% % [F,Ep,Cp,pE,pC,Eh] = spm_COVID(Y,pE,pC);
% % 
% % % compare true and estimated model parameters
% % %--------------------------------------------------------------------------
% % spm_figure('GetWin','Parameter estimates'); clf;
% % 
% % subplot(2,1,1)
% % spm_plot_ci(Ep,Cp), hold on, bar(spm_vec(pE),1/4), hold off
% % ylabel('log parameters','FontSize',16)
% % set(gca,'XTick',1:spm_length(Ep),'Xticklabel',str.names)
% % camorbit(90,0), axis square
% % 
% % subplot(2,1,2)
% % spm_plot_ci(Ep,Cp,[],[],'exp')
% % set(gca,'yLim',[0 32])
% % set(gca,'XTick',1:spm_length(Ep),'Xticklabel',str.names)
% % ylabel('Parameters','FontSize',16)
% % camorbit(90,0), axis square
% % 
% % % plot data fit
% % %--------------------------------------------------------------------------
% % spm_figure('GetWin','Predictions');
% % [Z,X] = spm_COVID_gen(Ep,M,4);
% % spm_COVID_plot(Z,X,Y)
% % 
% % 
